期刊文献+

CD40、P53在乳腺癌中的表达和生物学意义 被引量:2

The expression of CD40 molecule and P53 protein in breast carcinoma as well as underlying clinic significance
下载PDF
导出
摘要 目的研究乳腺癌组织及乳腺癌细胞表面共刺激分子CD40的表达,探讨CD40表达与癌组织转移、P53表达及临床病理特征之间的关系。方法采用免疫组化SP法检测58例石蜡包埋的乳腺癌组织中CD40、P53的表达,并选用36例癌旁正常乳腺组织作为对照。结果CD40在58例石蜡包埋的乳腺癌中阳性表达率37.9%,与癌旁正常组织中阳性率2.94%相比,差异有显著性意义(P<0.01),其表达与局部淋巴结转移有关(P<0.05),并与P53过表达有关(P<0.01)。结论乳腺良恶性细胞表面CD40表达差异可为乳腺良恶性肿瘤的鉴别诊断提供依据,CD40在乳腺癌中表达异常可望成为乳腺癌生物治疗的靶分子之一。 Objective To study the expression of co-stimulatory molecule CD40 on the surface of breast cancer and in human breast carcinoma,and to explore the correlations between CD40 expression and metastasis, P53 and clinical significanoes. Methods The CD40 and P53 expressions of 58 cases formalin-fixed and paraffin-embed tissue from breast carcinoma were studied by immunohistochemical technique, and 36 para-carcinoma normal breast tissue as a control. Results The position of CD40 in 58 cases of human breast carcinoma was 37.9%, and there were significant differences compared with that of the normal ones (2.94%) (P〈0,05); CD40 expression was correlated with lymph node matastasis (P〈0.05) and had a positive correlation with P53 expression (γ=0.52, P〈0.01 ), Conclusion The CD40 molecule in human benign and malignant tumors had a different expression and the abnormal expression of CD40 molecule may offer a reliable evidence for diagnosis, and had a relationship to expression of P53 protein.
出处 《中国现代医药杂志》 2006年第1期36-38,共3页 Modern Medicine Journal of China
基金 江苏省高校自然科学研究指导性计划项目(编号03KJD310190)
关键词 乳腺肿瘤 CD40分子 P53蛋白 Breast neoplasm CD40 molecule P53 protein
  • 相关文献

参考文献11

  • 1[1]Lash RH,Bauer TW,Hermann RE,et al.Partial mastectomy:pathologic findings and prognosis.Hum Pathol,1986,17(8):813-22 被引量:1
  • 2[2]Van Koollen C,Bancherean J.Functions of CD40 on B cells,dendritic cells and other cells.Curr Opin Immunol,1997,9 (3):330-341 被引量:1
  • 3[3]Vestal RE,Wingett LK,Kinght LK,et al.Expression of CD40 in breast,colon,lung and ovarian tumors.Proc Am Assoc Cancer Res,1997,38(A1550):230 被引量:1
  • 4[4]Altenburg A,Baldus SE Smola H,et al.CD40 ligand-CD40 interaction induce chemokines in cervical carcinoma cells in synergism with IFN-γ.J Immnol,1999,162(7):4140-4146 被引量:1
  • 5[5]Yamada M,Shiroko T,Kawaguchi Y,et al.CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I,ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors.Int J Cancer,2001,92 (4):589-599 被引量:1
  • 6[6]Ghosh M,Crocker J,Morris AG.CD40 and Bc12 expression in squamous cell carcinoma of the lung:correlation with apoptosis,survival,and other clinicopathological factors.J Pathol,1999,189(3):363-367 被引量:1
  • 7[7]Sabel MS,Yamada M,Kawaguchi Y,et al.CD40 expression on human lung cancer correlation with metastatic spread.Cancer Immumol Immumother,2000,49(2):101-108 被引量:1
  • 8[8]Turner JG,Rakhmilevich AL,Burdelya L,et al.Anti-CD40 antibody induces antitumor and antimetastatic effects:the role of NK cells.J Immunol,2001,166(1):89-94 被引量:1
  • 9[9]Kluth B,Hess S,Engelmanmll,et al.Endothelial expression of CD40 in renal cell carcinoma.Cancer Res,1999,57(5):2261-2267 被引量:1
  • 10[10]Young LS,Eliopoulos AG,Callagher JN,et al.CD40 and epithelial cells:across the great divide.Immunol Today,1998,19 (11):502-506 被引量:1

同被引文献17

  • 1李锐,陈卫昌,刘强,柴玉海.胃癌和癌旁组织CD40表达及其生物学意义[J].肿瘤学杂志,2005,11(2):120-122. 被引量:4
  • 2张峻,陈纪林,顾晴,关婷,陈曦.阻断CD40-CD40配体系统对动脉粥样硬化的影响[J].中国动脉硬化杂志,2006,14(2):119-122. 被引量:18
  • 3佟仲生,李淑芬.乳腺癌术后辅助化疗的进展[J].中国肿瘤临床,2007,34(13):772-775. 被引量:7
  • 4Inman BA, Frigola X, Dong H, et al. Costimulafion,coinhibition and cancer[J]. Curt Cancer Drug Targets, 2007, 7(1): 15-30. 被引量:1
  • 5Voorzanger-Rousselot N, Blay JY. Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells:an antocrinc anti-apoptotic role[J]. Leuk Lymphoma, 2004, 45(6): 1239-1245. 被引量:1
  • 6Salvatorelli E, Menna P, Cascegna S, et al. Paclitaxel and docetax el stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemothera pies[J]. J Pharmacol Exp Ther, 2006, 318(1): 424-433 被引量:1
  • 7von Minckwitz G. Docetaxel/anthracycline combinations for breast cancer treatment[J]. Expert Opin Pharmacother, 2007, 8(4): 485-495. 被引量:1
  • 8Melichar B, Patenia R, Gallardo S, et al. Expression of CD40 and growth-inhibitory activity of CD40 hgand in ovarian cancer cell lines[J]. Gynecol Oncol, 2007, 104(3): 707-713. 被引量:1
  • 9Bradshaw-Pierce EL, Steinhauer CA, Raben D, et al. Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma[J]. Mol Cancer Ther, 2008, 7(9): 3006-3017. 被引量:1
  • 10Hellings PW, Kasran A, Bullens D, et al. IL-10- and IL- 12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling[J]. J Immunol, 2006, 177(8): 5138-5144. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部